ImExHS (ASX:IME) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:IME ImExHS Ltd ASX:IME
52 GF Score
Price A$0.31
GF Value A$0.51
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is ImExHS Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

ASX:IME vs TMO, DHR, IDXX: Short Interest Comparison

For the Diagnostics & Research subindustry, ImExHS's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImExHS Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, ImExHS's Short Interest distribution charts can be found below:

* The bar in red indicates where ImExHS's Short Interest falls into.


ASX:IME
52GF Score
ImExHS Ltd ASX:IME
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ImExHS (ASX:IME) Overvalued in 2026?

Based on GuruFocus' analysis, ImExHS stock appears to be undervalued. The current stock price of A$0.31 is trading 39.2% below its estimated GF Value™ of A$0.51. GuruFocus considers ImExHS to be Possible Value Trap.

Key valuation signals for ASX:IME:

  • Short Interest:
  • GF Value™: A$0.51 vs. price of A$0.31 (39.2% below fair value)
  • GF Score™: 52/100 with 3 warning signs

No single metric tells the full story. See the ASX:IME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ImExHS Business Description

Address 32 Martin Place, Level 7, Sydney, NSW, AUS, 2020
ImExHS Ltd is a healthcare technology company engaged in the provision of medical imaging software and radiology services. The company develops and delivers enterprise imaging solutions, including radiology information systems and picture archiving and communication systems, as well as provides diagnostic imaging and teleradiology services to healthcare institutions. The company operates through two reportable segments: Software, which focuses on the development and sale of imaging systems and platforms, and Radiology Services, which provides diagnostic and teleradiology services to hospitals and medical facilities. It generates the majority of its revenue from the Radiology segment.
52GF Score

Get the complete analysis for ASX:IME

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.31
Price
A$0.51
GF Value